Main Street Research’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$638K Buy
7,484
+866
+13% +$77.2K 0.04% 77
2025
Q4
$523K Sell
6,618
-81
-1% -$6.35K 0.03% 76
2025
Q3
$536K Hold
6,699
0.03% 79
2025
Q2
$609K Hold
6,699
0.04% 66
2025
Q1
$628K Sell
6,699
-140
-2% -$12.5K 0.04% 65
2024
Q4
$622K Hold
6,839
0.04% 68
2024
Q3
$710K Sell
6,839
-100
-1% -$10.2K 0.04% 65
2024
Q2
$673K Buy
6,939
+100
+1% +$9.22K 0.04% 61
2024
Q1
$616K Sell
6,839
-1,139
-14% -$96.5K 0.04% 64
2023
Q4
$636K Sell
7,978
-475
-6% -$35.7K 0.05% 63
2023
Q3
$601K Hold
8,453
0.06% 63
2023
Q2
$651K Hold
8,453
0.1% 51
2023
Q1
$635K Hold
8,453
0.13% 48
2022
Q4
$666K Hold
8,453
0.16% 49
2022
Q3
$594K Hold
8,453
0.13% 49
2022
Q2
$677K Hold
8,453
0.18% 40
2022
Q1
$641K Sell
8,453
-492
-6% -$39K 0.06% 61
2021
Q4
$763K Sell
8,945
-594
-6% -$46.4K 0.06% 68
2021
Q3
$721K Buy
9,539
+286
+3% +$22.7K 0.06% 69
2021
Q2
$753K Sell
9,253
-39
-0.4% -$3.19K 0.06% 74
2021
Q1
$732K Sell
9,292
-569
-6% -$44.6K 0.07% 71
2020
Q4
$843K Sell
9,861
-967
-9% -$80K 0.09% 64
2020
Q3
$835K Sell
10,828
-100
-0.9% -$7.63K 0.11% 57
2020
Q2
$801K Hold
10,928
0.13% 52
2020
Q1
$725K Sell
10,928
-100
-0.9% -$7.05K 0.18% 44
2019
Q4
$759K Sell
11,028
-1,550
-12% -$106K 0.12% 53
2019
Q3
$925K Sell
12,578
-751
-6% -$54.5K 0.17% 47
2019
Q2
$955K Buy
13,329
+51
+0.4% +$3.62K 0.21% 41
2019
Q1
$910K Hold
13,278
0.29% 33
2018
Q4
$790K Hold
13,278
0.31% 31
2018
Q3
$889K Hold
13,278
0.13% 52
2018
Q2
$861K Sell
13,278
-32
-0.2% -$2.09K 0.13% 53
2018
Q1
$954K Sell
13,310
-198
-1% -$14.2K 0.15% 53
2017
Q4
$1.02M Sell
13,508
-141
-1% -$10.3K 0.16% 59
2017
Q3
$994K Sell
13,649
-949
-7% -$68.4K 0.16% 61
2017
Q2
$1.08M Sell
14,598
-100
-0.7% -$7.42K 0.18% 66
2017
Q1
$1.08M Sell
14,698
-380
-3% -$26.6K 0.19% 68
2016
Q4
$987K Sell
15,078
-83,662
-85% -$5.74M 0.19% 67
2016
Q3
$7.32M Buy
98,740
+4,292
+5% +$317K 1.43% 38
2016
Q2
$6.91M Buy
94,448
+11,393
+14% +$811K 1.43% 34
2016
Q1
$5.87M Buy
83,055
+1,949
+2% +$130K 1.51% 30
2015
Q4
$5.4M Buy
81,106
+5,115
+7% +$340K 1.15% 39
2015
Q3
$5.04M Buy
75,991
+7,928
+12% +$518K 1.18% 33
2015
Q2
$4.45M Buy
68,063
+7,998
+13% +$543K 0.91% 45
2015
Q1
$4.17M Buy
60,065
+6,770
+13% +$468K 0.9% 46
2014
Q4
$3.69M Buy
53,295
+5,955
+13% +$402K 0.79% 52
2014
Q3
$3.09M Buy
47,340
+4,955
+12% +$327K 0.69% 55
2014
Q2
$2.89M Buy
42,385
+1,215
+3% +$81.4K 0.68% 58
2014
Q1
$2.67M Buy
41,170
+4,215
+11% +$266K 0.65% 60
2013
Q4
$2.41M Sell
36,955
-100
-0.3% -$6.4K 0.6% 62
2013
Q3
$2.2M Sell
37,055
-10,582
-22% -$627K 0.59% 66
2013
Q2
$2.73M Buy
+47,637
New +$2.83M 0.82% 44

Other funds holding CL

Main Street Research's CL Position: Q1 2026 in Review

Main Street Research increased its Colgate-Palmolive (CL) stake by 13% in Q1 2026, buying an estimated $77.2K and bringing the position to 7,484 shares worth $638K. The position accounts for 0.04% of the portfolio, ranked #77.

Main Street Research first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.32M in Q3 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Main Street Research held 7,484 shares of Colgate-Palmolive worth $638K as of Q1 2026.
  • Main Street Research bought 866 Colgate-Palmolive shares in Q1 2026, an estimated $77.2K.
  • Colgate-Palmolive made up 0.04% of Main Street Research's portfolio in Q1 2026, its #77 holding.
  • Main Street Research first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Main Street Research's Colgate-Palmolive position peaked at $7.32M in Q3 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Main Street Research's 13F filing for Q1 2026, filed 30 Apr 2026.